What is the immediate management for a child experiencing a bronchopulmonary dysplasia (BPD) exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Bronchopulmonary Dysplasia (BPD) Exacerbation in Children

The immediate management of a child experiencing a BPD exacerbation should focus on optimizing respiratory support, maintaining adequate oxygenation with target saturations of 92-95%, and addressing any underlying causes of the exacerbation before initiating pulmonary vasodilator therapy if pulmonary hypertension is present. 1

Initial Assessment and Respiratory Support

  • Evaluate for hypoxemia and provide supplemental oxygen therapy to maintain oxygen saturations between 92% and 95%, which prevents adverse effects of hypoxia without increasing the risk of additional lung inflammation 1

  • Assess need for changes in respiratory support, including potential escalation to mechanical ventilation for severe exacerbations where the child fails to maintain near-normal ventilation or requires high FiO2 levels despite conservative treatment 1

  • If mechanical ventilation is required, consider:

    • Minimizing peak inspiratory pressures and avoiding large tidal volumes to reduce ventilator-associated lung injury 1
    • Using high-frequency oscillatory ventilation as an alternative when poor lung compliance, low volumes, and poor gas exchange complicate the clinical course 1, 2
    • Adopting a "chronic phase ventilation" approach for established severe BPD that focuses on reducing air trapping and improving ventilation-perfusion matching rather than aggressive weaning 2, 3

Evaluation for Underlying Causes

  • Perform comprehensive assessment for factors that may be exacerbating respiratory status 1:

    • Evaluate for chronic reflux and aspiration (consider upper GI series, pH/impedance probe, swallow studies)
    • Assess for structural airway abnormalities (tonsillar/adenoidal hypertrophy, vocal cord paralysis, subglottic stenosis, tracheomalacia)
    • Consider flexible bronchoscopy for diagnosis of anatomic and dynamic airway lesions
    • Evaluate for bronchoreactivity and treat as needed
    • Assess for pulmonary edema and optimize airway function
  • Consider sleep study if there are concerns for intermittent hypoxia episodes, as brief "spot checks" of oxygenation are insufficient for determining appropriate oxygen requirements 1

Management of Pulmonary Hypertension (PH)

  • Screen for pulmonary hypertension with echocardiogram, as PH is common in BPD exacerbations and associated with higher morbidity and mortality 1

  • For infants with established BPD and symptomatic PH, consider the following therapies after optimizing respiratory support 1:

    • Inhaled nitric oxide (iNO) at initial doses of 10-20 ppm, which can be weaned to 2-10 ppm for maintenance therapy to enhance ventilation-perfusion matching 1, 4
    • Sildenafil (0.5-2 mg/kg three times daily) has shown improvement in PH by echocardiogram in 88% of patients with chronic lung disease and PH 1
    • Calcium channel blockers have shown short-term benefits but may cause systemic hypotension and have poor acute response compared to iNO 1

Monitoring and Follow-up

  • Monitor response to therapy with serial echocardiograms, initially every 2-4 weeks with therapy initiation and then at 4-6 month intervals with stable disease 1

  • Consider repeat cardiac catheterization for patients being treated for PH who experience clinical deterioration or worsening PH by echocardiogram 1

  • Monitor for potential complications of therapy, including systemic hypotension with vasodilators and ventilation-perfusion mismatch with intravenous prostacyclin analogs 1

Important Caveats

  • Despite growing use of pulmonary vasodilator therapy for BPD-associated PH, data demonstrating efficacy are extremely limited; these agents should only be used after thorough diagnostic evaluations and aggressive management of the underlying lung disease 1

  • Abrupt worsening of PH may reflect several factors, including poor compliance with oxygen therapy, medication issues, or development of pulmonary vein stenosis 1

  • For infants with severe BPD requiring long-term ventilation, shifting from an acute care ventilation model (frequent blood gases and support adjustments) to a chronic care model (less frequent ventilator adjustments with adequate positive support) may better promote ongoing lung growth and repair 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.